Quantcast

Latest estradiol Stories

2014-08-17 23:02:07

As Merck Moves Forward to Resolve 3,800 Pending NuvaRing Lawsuits in the U.S., Health Canada Issues Safety Alert for the Contraceptive NuvaRing Citing It May Be Harmful for Some Women Columbus, OH (PRWEB) August 17, 2014 As Merck looks to settle thousands of NuvaRing lawsuits alleging deep vein thrombosis and pulmonary embolisms in the U.S. under MDL 1964, Wright & Schulte LLC reports that Health Canada recently ordered new user restrictions for the use of the contraceptive device...

2014-07-15 16:25:16

NEW YORK, July 15, 2014 /PRNewswire/ -- According to BCC Research, the global market for women's health therapeutics is expected to reach $22.5 billion in 2018. Due to a variety of factors, such as an aging worldwide population, an increasing awareness among patients and physicians, the introduction of new therapies into the market, and the overall disease pattern and treatment differences between men and women, this market is expected to grow at a CAGR of 3.5% over the next five...

2014-05-29 20:22:54

New offering through an agreement with Meda AB expands Mission's women's healthcare options SAN ANTONIO, May 29, 2014 /PRNewswire/ -- Mission Pharmacal Company has begun exclusive promotion of Elestrin® (estradiol gel) 0.06% in the United States through an agreement with Meda AB. Elestrin is a prescription medicine approved by the Food and Drug Administration (FDA) for use as a topical hormone replacement gel to treat moderate-to-severe hot flashes due to menopause. Using estrogen-alone may...

2014-05-27 12:10:00

Brigham and Women's Hospital Both treatments shown effective for hot flashes and night sweats A new research study from Brigham and Women's Hospital (BWH) that compares low-dose oral estrogen and low-dose non-hormonal venlafaxine hydrochloride extended release (XR) to placebo were both found effective in reducing the number of hot flashes and night sweats reported by menopausal women. The study is the first clinical trial to simultaneously evaluate estrogen therapy (ET), known as the...

2014-04-16 16:30:50

DUBLIN, April 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/q7jzmk/sustained_release) has announced the addition of the "Concise Analysis of International Sustained Release Injectables to 2020" [http://www.researchandmarkets.com/research/q7jzmk/sustained_release ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Formulations, Dosing, Devices, Markets and Forecasts The ability...

2014-03-24 16:24:14

MAPLE GROVE, Minn., March 24, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), a fully integrated pharmaceutical company committed to the development of new treatments for diseases of the central nervous system (CNS), today announced that it has entered into a definitive agreement under which New Jersey-based Vertical Pharmaceuticals, LLC has acquired Upsher-Smith's rights to Divigel(®) (estradiol gel) 0.1%, Nexa(®) Plus Rx Prenatal Vitamin, and Provella(®), a...

2014-03-24 16:24:09

Avista Capital Partners-Backed Company to Continue Add-On Acquisition Strategy SAYREVILLE, N.J., March 24, 2014 /PRNewswire/ -- Vertical Pharmaceuticals, LLC, a wholly owned subsidiary of Vertical / Trigen Holdings, LLC ("Vertical / Trigen"), today announced that it has acquired the rights to three branded women's health products from Upsher-Smith Laboratories, Inc. The terms of the transaction were not disclosed. Vertical / Trigen is a portfolio company of Avista Capital Partners....

2014-03-13 17:07:09

When initiated soon after menopause, hormone therapy with estradiol prevented degeneration in key brain regions of women who were at heightened dementia risk, according to a new study led by Stanford University School of Medicine researchers. The investigators also found that another type of hormone therapy, marketed under the brand name Premarin, was far less protective. Premarin is a mixture of 30-plus substances derived from the urine of pregnant mares. Estradiol — the dominant...

2014-02-11 08:25:00

DUBLIN, Feb. 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5nldqw/sustained_release ) has announced the addition of the "Sustained Release Injectables to 2020" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Formulations, Dosing, Devices, Markets and Forecasts The ability to formulate injectable drugs to increase the duration of efficacy for a given dose and simultaneously reduce the dosing frequency...

2013-12-20 23:03:55

Alert: Drug Allegedly Linked to Serious Injuries and Deaths in Users DALLAS (PRWEB) December 20, 2013 The national plaintiffs’ law firm of Baron & Budd is now handling lawsuits on behalf of women who have used the contraceptive device NuvaRing, also known as the etonogestrel/ethinyl estradiol Vaginal Ring. Baron & Budd NuvaRing lawyers will represent women who allegedly suffered serious side effects or even died after using the birth control drug. The NuvaRing, produced by...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related